Representative before the EPO

Company dna symbiosis ip limited
no operation time available
3 offices
active in Legal Services

Robert Charles Docherty has worked on the following 67 EPO patent applications which have been published in the last five years:

EP11787400

PERSONAL GLUCOSE METERS FOR DETECTION AND QUANTIFICATION OF A BROAD RANGE OF ANALYTES

IPC classification:
C12Q 1/00
Applicant:
Board of Trustees of the University of Illinois
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
PATENT GRANTED
EP12712144

VITAMIN D COMPOSITION

IPC classification:
A61K 9/48, A61K 31/593, A61P 3/02
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP12715124

MODIFIED RECEPTOR FUSION PROTEINS

IPC classification:
C07K 14/61, C07K 14/71
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP12779794

QUANTITATIVE NUCLEASE PROTECTION ASSAY (QNPA) AND SEQUENCING (QNPS) IMPROVEMENTS

IPC classification:
C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
PATENT GRANTED
EP11868918

METHODS OF DETECTING GENE FUSIONS

IPC classification:
C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12808072

HIV-1 GENOTYPING ASSAY FOR GLOBAL SURVEILLANCE OF HIV-1 DRUG RESISTANCE

IPC classification:
C12Q 1/68
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP12738664

PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES

IPC classification:
A41D 27/08, A61K 41/00, A61K 49/00
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP12822836

METHODS AND COMPOSITIONS FOR IMPROVING SPERM FUNCTIONALITY

IPC classification:
A61K 35/52, A61K 38/17, A61K 47/48, A61P 15/08
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
APPLICATION REFUSED
EP12814318

METHOD AND KIT FOR DNA TYPING OF HLA GENE

IPC classification:
C12N 15/09, C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP12772367

INTRACELLULAR CELL SELECTION

IPC classification:
B03C 1/00, C07K 17/14, C12N 5/00, G01N 33/543, G01N 33/569, G01N 33/574, G01N 33/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12834920

METHODS OF CO-DETECTING MRNA AND SMALL NON-CODING RNA

IPC classification:
C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP14159277

Compositions comprising agents that inhibit neuroplilin and tolloid like 2

IPC classification:
A61K 31/713, C07K 16/28, C07K 16/30, C12N 15/113, C12Q 1/68
Applicant:
University of York
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12788628

PULMONARY HYPERTENSION

IPC classification:
C07K 16/28
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12788239

PULMONARY HYPERTENSION

IPC classification:
C07K 16/28
Applicant:
University of Sheffield
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP12808870

POLYPEPTIDE ADJUVANT

IPC classification:
A61K 39/095, C12N 9/52
Applicant:
University of Sheffield
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12806617

TREATMENT OF ADRENAL INSUFFICIENCY

IPC classification:
A61K 9/50, A61K 31/573
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP11711616

CANCER VACCINE

IPC classification:
A61K 39/00, A61P 35/00, A61P 35/02, C07K 16/28
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13709499

HYDROCORTISONE CONTROLLED RELEASE FORMULATION

IPC classification:
A61K 9/50, A61K 31/573
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP13760821

ADENOVIRAL TUMOR DIAGNOSTICS

IPC classification:
C12Q 1/70, G01N 33/569, G01N 33/574
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP13760608

SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS

IPC classification:
A61P 35/00, C12N 15/34, C12N 15/62
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP12708369

ANTIGENIC GLY1 POLYPEPTIDES

IPC classification:
A61K 39/02, A61P 31/04, C07K 14/195
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
APPLICATION WITHDRAWN
EP13765148

PHOTOVOLTAIC CELL WITH GRAPHENE-FERROELECTRIC ELECTRODE

IPC classification:
H01G 9/20, H01L 31/0224, H01L 31/0256, H01L 51/46
Applicant:
National University of Singapore
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP13728235

TREATMENT OF RESPIRATORY DEPRESSION

IPC classification:
A61K 31/485, A61K 31/554, A61K 45/06, A61P 11/00
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP13790486

METHODS OF GROWING UNIFORM, LARGE-SCALE, MULTILAYER GRAPHENE FILMS

IPC classification:
B82Y 40/00, C01B 31/04, C30B 25/00
Applicant:
National University of Singapore
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP13800697

ENDOLUMINAL VACUUM THERAPY DEVICE

IPC classification:
A61M 1/00
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP13806645

MOLECULAR MALIGNANCY IN MELANOCYTIC LESIONS

IPC classification:
C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP13810495

TARGETED RNA-SEQ METHODS AND MATERIALS FOR THE DIAGNOSIS OF PROSTATE CANCER

IPC classification:
C12N 15/11, C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP13809718

NUCLEASE PROTECTION METHODS FOR DETECTION OF NUCLEOTIDE VARIANTS

IPC classification:
C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP13813993

METHODS FOR DETERMINING PERSONALIZED TREATMENT COMPOSITIONS FOR PROSTATE CANCER AND BREAST CANCER

IPC classification:
A61K 38/16, C12N 5/0783, C12N 5/09, G01N 33/574
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13825728

CELL CULTURE

IPC classification:
B01L 3/00, C12M 1/18
Applicant:
National University of Singapore
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Osha Liang SARL
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP14197613

Modified growth hormone polypeptides

IPC classification:
C07K 14/61
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14705855

GLYCOSYLATION METHOD

IPC classification:
A61K 39/02, A61K 47/48, C12N 9/10, C12N 15/63, C12P 21/00
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP14743022

ANGIOPOIETIN-RELATED PROTEIN 4 (CANGPTL4) AS A DIAGNOSTIC BIOMARKER FOR ACUTE LUNG DAMAGE

IPC classification:
A61K 39/00, C07K 16/18, C12N 5/24
Applicant:
Nanyang Technological University
Applicant:
National University of Singapore
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP14703622

GLYCOCONJUGATE VACCINES

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/385, C07K 14/195
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14745551

PREVENTION & TREATMENT OF NEUROPATHY

IPC classification:
A61F 7/00
Applicant:
National University of Singapore
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP14753632

A POLIPOPROTEIN C3 (APOCIII) ANTAGONISTS AND METHODS OF THEIR USE TO REMOVE APOCIII INHIBITION OF LIPOPROTEIN LIPASE (LPL)

IPC classification:
A61P 3/06
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14768337

SUBTYPING LUNG CANCERS

IPC classification:
C40B 30/04
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14770520

ONCOLYTIC ADENOVIRUS COMPOSITIONS

IPC classification:
C12N 15/861
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14727028

COMPOSITION COMPRISING HYDROCORTISONE

IPC classification:
A61K 9/50, A61K 31/57
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14769814

ACTIVATED SOY POD FIBER

IPC classification:
A61K 31/35
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14787709

VITAMIN D RECEPTOR/SMAD GENOMIC CIRCUIT GATES FIBROTIC RESPONSE

IPC classification:
A61K 9/00, A61K 31/59, A61K 31/592, A61K 31/593, A61K 47/42, A61K 47/44, A61K 47/48, A61P 1/16, A61P 1/18, A61P 13/12, A61P 31/12
Applicant:
University of Sydney - Commercial Development and Industry Partnerships
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14794106

DIAGNOSTIC MARKER COMPOSITION COMPRISING APOLIPOPROTEIN M FOR ALZHEIMER'S DISEASE

IPC classification:
C12Q 1/68, G01N 33/53, G01N 33/68
Applicant:
Kyungpook National University Industry-Academic Cooperation Foundation
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP14806812

VITAMIN D RECEPTOR AGONISTS TO TREAT DISEASES INVOLVING CXCL12 ACTIVITY

IPC classification:
A61K 31/592, A61P 1/18, A61P 3/08, A61P 3/14, A61P 5/48, A61P 35/00
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP14795192

HLA GENE MULTIPLEX DNA TYPING METHOD AND KIT

IPC classification:
C12N 15/09, C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14814051

METHODS OF TREATING MUSCULAR DYSTROPHY

IPC classification:
A61K 31/16, A61P 21/00
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP14733704

PRODUCTION OF HUMAN PULMONARY SURFACTANT PROTEIN B IN PLANTS

IPC classification:
C07K 14/785, C12N 15/82
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
PATENT GRANTED
EP14841093

MICRO-TEXTURED SURFACE WITH INTEGRATED MICRO-MIRRORS FOR 3D MULTI-SCALE MICROSCOPY

IPC classification:
B01L 3/00, G01N 21/03, G02B 21/06
Applicant:
National University of Singapore
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
GRANT OF PATENT INTENDED
EP14772171

ANTI-VIRAL THERAPY

IPC classification:
A61K 31/7088, C12N 15/115
Applicant:
University of Leeds
Applicant:
University of York
Applicant:
University of Helsinki (Helsingin yliopisto)
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP14790866

METHODS OF MODULATING ERYTHROPOIESIS WITH ARGININE VASOPRESSIN RECEPTOR 1B MOLECULES

IPC classification:
A61K 31/404, A61K 38/11, A61K 38/18, A61P 7/04, A61P 7/06
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP12706301

ANTIGENIC GLY1 POLYPEPTIDE

IPC classification:
A61K 39/095, A61P 31/04, C07K 14/22
Applicant:
University of Sheffield
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14856609

MUTATED FIBROBLAST GROWTH FACTOR (FGF) 1 AND METHODS OF USE

IPC classification:
A61K 38/18, A61P 3/04, A61P 3/08, C07K 14/50, C07K 19/00
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14859794

METHODS FOR DETECTING NUCLEIC ACIDS

IPC classification:
C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14866271

SIMPLE METHOD AND KIT FOR DNA PROFILING OF HLA GENES BY HIGH-THROUGHPUT MASSIVELY PARALLEL SEQUENCER

IPC classification:
C12N 15/09, C12Q 1/68
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP14827515

DESATURASE NUCLEIC ACIDS AND POLYPEPTIDES

IPC classification:
A01H 5/10, A01H 5/12, C11B 1/00, C12N 9/02, C12N 15/82
Applicant:
University of York
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION IN PROGRESS
EP15702003

DITERPENOID SYNTHESIS

IPC classification:
C12N 9/02, C12N 15/82
Applicant:
University of York
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP15744002

METHODS AND COMPOSITIONS FOR PRODUCING A CELL EXPRESSING A T CELL RECEPTOR

IPC classification:
A61K 38/17, C07K 14/725, C12N 5/10, C12N 15/09, C12N 15/12, C12P 21/02
Applicant:
University Health Network (UHN)
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP15747042

INCREASING STORAGE OF VITAMIN A, VITAMIN D AND/OR LIPIDS

IPC classification:
A61K 9/51, A61P 35/00
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP15727730

FLOWER PRESERVATION METHOD AND DEVICE

IPC classification:
A01N 3/02, A01N 59/02, B65D 85/50
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP15728581

NOVEL CYTOCHROME P450 FUSION PROTEIN

IPC classification:
C12N 5/04, C12N 9/02, C12N 15/53, C12N 15/82
Applicant:
University of York
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP15724025

SYNTHETIC PROMOTER CONSTRUCT FOR TRANSGENE EXPRESSION

IPC classification:
A01H 5/00, C12N 15/82
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP15727803

METHODS OF MICROORGANISM IMMOBILIZATION

IPC classification:
C12Q 1/02, G01N 33/50, G01N 33/543
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP15792446

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS

IPC classification:
A61K 39/00, A61K 39/395
Applicant:
Teva Pharmaceuticals International GmbH
Applicant:
The Regents of the University of California
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP15760320

PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO

IPC classification:
A61K 41/00, A61K 49/00, A61K 47/50
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
EXAMINATION REQUESTED
EP15843893

ONCOLYTIC TUMOR VIRUSES AND METHODS OF USE

IPC classification:
A61K 35/761, A61P 35/00, C12N 7/01
Agent:
Robert Charles Docherty, Symbiosis IP Limited
Status:
Request for examination was made

Please Sign in to use this feature